Our findings suggested that circRNA_069718 promoted TNBC progression via Wnt/beta-catenin pathway and could serve as a novel therapeutic target for TNBC treatment.
CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/beta-catenin pathway.